Clinical Trials

Over 100 million animals are used in research worldwide annually, a figure that has fueled decades of ethical debate and scientific scrutiny. …

Nearly 40% of individuals regaining weight after discontinuing GLP-1 receptor agonists experienced a significantly elevated risk of major adverse cardiovascular events (MACE) …

The race to conquer obesity is entering a new phase, one where simply shedding pounds isn’t enough. Swedish biotech Atrogi has begun …

FDA Approves Leucovorin for Cerebral Folate Deficiency, Following Autism Research Discussion In a landmark decision, the Food and Drug Administration (FDA) has …

HUTCHMED Initiates Clinical Trial for Novel Solid Tumor Therapy, HMPL-A580 In a significant step forward for cancer research, HUTCHMED has begun a …

Roche’s Fenebrutinib Shows Promise in Relapsed or Refractory Marginal Zone Lymphoma In a significant advancement for patients battling B-cell malignancies, Roche announced …

Nearly 50 million US adults suffer from chronic pain, costing the nation an estimated $560 billion annually. But a growing body of …

Pluvicto and the Precision Oncology Revolution: Predicting the Next Wave of Personalized Prostate Cancer Treatment Despite significant advancements, prostate cancer remains a …

Grail’s Galleri Cancer Screening Test Shows Limited Benefit in Landmark Study, Stock Plummets Shares of Grail, the biotech firm pioneering multi-cancer early …

Eli Lilly Invests $100 Million in Inflammation Drug Rights from CSL In a significant move signaling heightened competition within the burgeoning field …